Literature DB >> 16558095

Immunogenicity of Ribosomal Preparations from Yeast Cells of Histoplasma capsulatum.

C Feit1, R P Tewari.   

Abstract

Protective immunity was elicited by immunization of mice with ribosomal preparations from yeast cells of Histoplasma capsulatum. Ribosomes from disrupted cells were isolated by differential centrifugation using sodium dodecyl sulfate. These preparations contained 55% protein and 45% ribonucleic acid and sedimented as a single peak with a sedimentation coefficient of 77S on sucrose density gradient analysis. Mice immunized subcutaneously with ribosomes, with or without adjuvant, were challenged intravenously with 8 x 10(6) yeast cells of H. capsulatum. Significant protection was induced by ribosomes and was greatly enhanced by adjuvants. Protection measured by 30-day survival compared favorably with the immunoprotection assessed by absence of lung lesions and negative spleen cultures. Treatment of ribosomes with ribonuclease before immunization reduced protection by 85%, whereas trypsin and Pronase reduced the protection by 50 to 55%. These findings indicate that both intact ribosomal ribonucleic acid and protein are necessary for maximal immunogenicity of Histoplasma ribosomes.

Entities:  

Year:  1974        PMID: 16558095      PMCID: PMC423067          DOI: 10.1128/iai.10.5.1091-1097.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Isolation of protective somatic antigen from Vibrio cholerae (Ogawa) ribosomal preparations.

Authors:  R Jensen; B Gregory; J Naylor; P Actor
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

2.  Preparation and effect of different adjuvants on the immunogenic activity of mycobacterial ribosomal fraction.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

3.  Immunogenicity of a ribosomal antigen of Leishmania enriettii.

Authors:  P M Preston; D C Dumonde
Journal:  Trans R Soc Trop Med Hyg       Date:  1971       Impact factor: 2.184

4.  Comparative pathogenicity of albino and brown types of Histoplasma capsulatum for mice.

Authors:  R P Tewari; F J Berkhout
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

5.  Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

6.  Antibacterial immunity induced by ribosomal vaccines.

Authors:  S H Winston; L J Berry
Journal:  J Reticuloendothel Soc       Date:  1970-07

7.  Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.

Authors:  M R Venneman; N J Bigley
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

8.  Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

9.  Response of mice to injection of ribosomal fraction from group B Neisseria meningitidis.

Authors:  D W Thomas; E Weiss
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

10.  Ribonucleic acid-protein fractions of virulent Salmonella typhimurium as protective immunogens.

Authors:  R A Smith; N J Bigley
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

View more
  27 in total

Review 1.  Fungal ribosomal vaccines. I. Histoplasma and Candida vaccines.

Authors:  E Segal
Journal:  Mycopathologia       Date:  1989-01       Impact factor: 2.574

2.  Serial enzymatic hydrolysis of cell walls of two serotypes of yeast-form Histoplasma capsulatum with alpha(1 leads to 3)-glucanase, beta(1 leads to 3)-glucanase, pronase, and chitinase.

Authors:  E Reiss
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

3.  Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum.

Authors:  R P Tewari; D Sharma; M Solotorovsky; R Lafemina; J Balint
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

4.  Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.

Authors:  P Hoops; N E Prather; J Berry; J M Ravel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

5.  Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

Authors:  W O Schalla; W Johnson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

6.  Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.

Authors:  M Riottot; J M Fournier; J Pillot
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

7.  Ribonuclease-sensitive ribosomal vaccines.

Authors:  R Gonggrijp; A C Antonissen; J F van den Bosch; C P van Boven
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

Review 8.  Histoplasma capsulatum at the host-pathogen interface.

Authors:  Joshua D Nosanchuk; Attila Gacser
Journal:  Microbes Infect       Date:  2008-07-10       Impact factor: 2.700

9.  Immunogenicity of soluble and particulate antigens from Leishmania donovani: effect of glucan as an adjuvant.

Authors:  J A Cook; T W Holbrook
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

10.  Variability of protection in inbred mice induced by a ribosomal vaccine prepared from Salmonella typhimurium.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.